Lyell Immunopharma Inc. (LYEL) Balance Sheet Analysis - Assets, Liabilities & Financial Position - Stocknear
Stocknear Logo Stocknear
/
Popular
  • KO Coca Cola Company Stock
  • TSLA Tesla Inc Stock
  • AMD Advanced Micro Devices Stock
  • SPY SPDR S&P 500 ETF Trust ETF
  • NVDA Nvidia Stock
    • Start Trial

    Lyell Immunopharma Inc.

    NASDAQ: LYEL · Real-Time Price · USD
    17.75
    1.94 (12.27%)
    At close: Oct 03, 2025, 3:59 PM
    17.99
    1.35%
    After-hours: Oct 03, 2025, 07:29 PM EDT

    Lyell Immunopharma Balance Sheet Statement

    Financials in USD. Fiscal year is January - December.

    undefined peaked at n/a in undefined and hit its lowest at n/a in undefined. Over the past five years, it has declined by undefined%.

    Fiscal Year FY 2024 FY 2023 FY 2022 FY 2021
    Period Ending Dec 31, 2024 Dec 31, 2023 Dec 31, 2022 Dec 31, 2021
    Cash & Equivalents
    		 105.6M 145.65M 123.55M 293.83M
    Short-Term Investments
    		 264.93M 400.58M 516.6M 320.97M
    Long-Term Investments
    		 32.01M 48.51M 115.04M 330.53M
    Other Long-Term Assets
    		 6.31M 4.52M 4.96M 3.95M
    Receivables
    		 n/a n/a n/a n/a
    Inventory
    		 n/a n/a n/a n/a
    Other Current Assets
    		 9.07M 8.46M 11.14M 11.49M
    Total Current Assets
    		 379.59M 554.69M 651.29M 626.29M
    Property-Plant & Equipment
    		 72.94M 142.32M 166.26M 166.64M
    Goodwill & Intangibles
    		 n/a n/a n/a n/a
    Total Long-Term Assets
    		 111.27M 195.34M 286.27M 501.12M
    Total Assets
    		 490.86M 750.03M 937.56M 1.13B
    Account Payables
    		 5.37M 4.82M 3.92M 3.21M
    Deferred Revenue
    		 n/a n/a 21.87M 4.99M
    Short-Term Debt
    		 7.97M n/a n/a n/a
    Other Current Liabilities
    		 14.74M 8.79M 13.13M 20.08M
    Total Current Liabilities
    		 53.79M 34.52M 37.03M 46.74M
    Long-Term Debt
    		 n/a n/a 63.17M 66.65M
    Other Long-Term Liabilities
    		 3.25M 3.66M -59.05M -62.08M
    Total Long-Term Liabilities
    		 54.25M 60.56M 67.28M 150.88M
    Total Liabilities
    		 108.03M 95.08M 104.31M 197.62M
    Total Debt
    		 58.97M 63.17M 67.7M 67.82M
    Book Value
    		 382.82M 654.95M 833.25M 929.79M
    Book Value Per Share
    		 1.46 2.61 3.37 3.83
    Common Stock
    		 29K 25K 25K 24K
    Retained Earnings
    		 -1.35B -1B -767.48M -584.36M
    Comprehensive Income
    		 291K -94K -7.6M -1.62M
    Shareholders Equity
    		 382.82M 654.95M 833.25M 929.79M
    Total Investments
    		 296.94M 449.08M 631.64M 651.5M

    Add to Watchlist